/
RSS Feed
Matthias Pfisterer, University Hospital Basel
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 422-11. Lancet 2005:366:921
Clopidogrel therapy may need to be prolonged among patients treated with angioplasty plus drug eluting stent implantation as compared with those getting bare metal stents. That’s the outcome of the BASKET (Basel Stent Cost Effectiveness Trials) study announced at the American College of Cardiology conference in Atlanta. Sarah Maxwell heard results from Matthias Pfisterer from Basel.
[audio:https://www.audiomedica.com/podcasting/acc2006/matthias_pfisterer.mp3] American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 422-11. Lancet 2005:366:921
Clopidogrel therapy may need to be prolonged among patients treated with angioplasty plus drug eluting stent implantation as compared with those getting bare metal stents. That’s the outcome of the BASKET (Basel Stent Cost Effectiveness Trials) study announced at the American College of Cardiology conference in Atlanta. Sarah Maxwell heard results from Matthias Pfisterer from Basel.
